S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
NASDAQ:MBRX

Moleculin Biotech News Headlines

$3.87
+0.01 (+0.26 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.16
Now: $3.87
$3.90
50-Day Range
$0.83
MA: $4.96
$6.42
52-Week Range
$1.94
Now: $3.87
$11.82
Volume1.99 million shs
Average Volume3.28 million shs
Market Capitalization$101.70 million
P/E RatioN/A
Dividend YieldN/A
Beta2.11

Headlines

Moleculin Biotech (NASDAQ MBRX) News Headlines Today

Source:
SourceHeadline
InvestorNewsBreaks - Moleculin Biotech Inc. (NASDAQ: MBRX) Secures $78M in Underwritten Public OfferingInvestorNewsBreaks - Moleculin Biotech Inc. (NASDAQ: MBRX) Secures $78M in Underwritten Public Offering
marketwatch.com - March 6 at 8:58 AM
Moleculin Biotech (NASDAQ:MBRX)  Shares Down 6.1% Moleculin Biotech (NASDAQ:MBRX) Shares Down 6.1%
americanbankingnews.com - March 3 at 8:12 PM
Short Interest in Moleculin Biotech, Inc. (NASDAQ:MBRX) Decreases By 84.9%Short Interest in Moleculin Biotech, Inc. (NASDAQ:MBRX) Decreases By 84.9%
americanbankingnews.com - February 28 at 2:36 AM
Moleculin Biotech (NASDAQ:MBRX)  Shares Down 5.7% Moleculin Biotech (NASDAQ:MBRX) Shares Down 5.7%
americanbankingnews.com - February 23 at 7:01 PM
-$0.61 Earnings Per Share Expected for Moleculin Biotech, Inc. (NASDAQ:MBRX) This Quarter-$0.61 Earnings Per Share Expected for Moleculin Biotech, Inc. (NASDAQ:MBRX) This Quarter
americanbankingnews.com - February 23 at 8:40 AM
Moleculin Biotech (NASDAQ:MBRX) Shares Cross Below 50 Day Moving Average of $5.23Moleculin Biotech (NASDAQ:MBRX) Shares Cross Below 50 Day Moving Average of $5.23
americanbankingnews.com - February 18 at 4:21 AM
Moleculin Biotech (NASDAQ:MBRX) Stock Price Up 7.4%Moleculin Biotech (NASDAQ:MBRX) Stock Price Up 7.4%
americanbankingnews.com - February 10 at 7:34 PM
Moleculin Announces Full Exercise of Over-Allotment OptionMoleculin Announces Full Exercise of Over-Allotment Option
finance.yahoo.com - February 10 at 6:55 PM
Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung MetastasesMoleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases
finance.yahoo.com - February 8 at 9:44 AM
WPD Pharmaceuticals Licensor Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model of Annamycin DrugWPD Pharmaceuticals' Licensor Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model of Annamycin Drug
benzinga.com - February 6 at 7:05 AM
WPD Pharmaceuticals’ Licensor Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model of Annamycin DrugWPD Pharmaceuticals’ Licensor Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model of Annamycin Drug
finance.yahoo.com - February 5 at 10:39 AM
Is Moleculin Biotech (NASDAQ:MBRX) In A Good Position To Deliver On Growth Plans?Is Moleculin Biotech (NASDAQ:MBRX) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - February 4 at 12:32 PM
Moleculin Announces Pricing Of $67.8 Million Underwritten Public OfferingMoleculin Announces Pricing Of $67.8 Million Underwritten Public Offering
finance.yahoo.com - February 3 at 12:48 PM
Stock Alert: Moleculin Biotech Surges 70%Stock Alert: Moleculin Biotech Surges 70%
nasdaq.com - February 2 at 3:00 PM
Moleculin Biotech Announces Reverse Stock SplitMoleculin Biotech Announces Reverse Stock Split
finanznachrichten.de - February 1 at 7:34 AM
Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma TrialMoleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial
finance.yahoo.com - February 1 at 7:34 AM
Moleculin Announces Reverse Stock SplitMoleculin Announces Reverse Stock Split
finance.yahoo.com - January 29 at 9:31 AM
Moleculin Biotech IncMoleculin Biotech Inc
bloomberg.com - January 28 at 6:27 PM
Moleculin Biotech (MBRX) Jumps: Stock Rises 8.5%Moleculin Biotech (MBRX) Jumps: Stock Rises 8.5%
finance.yahoo.com - January 12 at 12:22 PM
Moleculin Stock Rises After FDA Grants Annamycin Orphan Drug Designation For Soft Tissue SarcomasMoleculin Stock Rises After FDA Grants Annamycin Orphan Drug Designation For Soft Tissue Sarcomas
nasdaq.com - December 29 at 9:17 AM
Moleculin Announces FDA Permission to Begin Clinical Study of Annamycin for Sarcoma Lung MetastasesMoleculin Announces FDA Permission to Begin Clinical Study of Annamycin for Sarcoma Lung Metastases
finance.yahoo.com - December 17 at 12:22 PM
Moleculin To Present Antitumor Activity of Annamycin in Combination with Ara-C in AML at American Society for Hematology Annual ConferenceMoleculin To Present Antitumor Activity of Annamycin in Combination with Ara-C in AML at American Society for Hematology Annual Conference
finance.yahoo.com - December 3 at 8:14 AM
FDA Rare Pediatric tags for WP1066 lifts Moleculin BiotechFDA Rare Pediatric tags for WP1066 lifts Moleculin Biotech
seekingalpha.com - December 1 at 4:55 PM
Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066
finance.yahoo.com - December 1 at 4:55 PM
Global Acute Myeloid Leukemia Therapeutics Market Could Exceed $3.5 Billion By 2027Global Acute Myeloid Leukemia Therapeutics Market Could Exceed $3.5 Billion By 2027
marketwatch.com - November 19 at 1:07 PM
Moleculin Biotechs annamycin shows encouraging action in animal studyMoleculin Biotech's annamycin shows encouraging action in animal study
seekingalpha.com - November 19 at 8:07 AM
Moleculin Announces New Data Demonstrating Synergistic Antitumor Activity of Annamycin Combination with Ara-C in AMLMoleculin Announces New Data Demonstrating Synergistic Antitumor Activity of Annamycin Combination with Ara-C in AML
finance.yahoo.com - November 19 at 8:07 AM
Moleculin Biotech, Inc. Reports Financial Results for the Quarter Ended September 30, 2020Moleculin Biotech, Inc. Reports Financial Results for the Quarter Ended September 30, 2020
finance.yahoo.com - November 13 at 12:26 PM
Moleculin further collaborates to advance WP1122 in COVID-19Moleculin further collaborates to advance WP1122 in COVID-19
seekingalpha.com - October 29 at 8:54 AM
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
finance.yahoo.com - October 29 at 8:54 AM
Moleculin to Participate in Panel at ROTH Capital's "COVID-19 Therapeutics in Development" Healthcare EventMoleculin to Participate in Panel at ROTH Capital's "COVID-19 Therapeutics in Development" Healthcare Event
finance.yahoo.com - October 27 at 9:01 AM
Moleculin Announces Independent Study Validates Annamycin's Ability to Target Lung Localized TumorsMoleculin Announces Independent Study Validates Annamycin's Ability to Target Lung Localized Tumors
finance.yahoo.com - October 21 at 9:24 AM
Moleculin Announces Additional Positive Interim Results in Adult Glioblastoma Clinical TrialMoleculin Announces Additional Positive Interim Results in Adult Glioblastoma Clinical Trial
prnewswire.com - October 13 at 9:05 AM
Targeted Therapies for Glioblastoma Becoming Critical As Increasing Incidence of Brain Cancer RisesTargeted Therapies for Glioblastoma Becoming Critical As Increasing Incidence of Brain Cancer Rises
prnewswire.com - October 13 at 9:05 AM
Moleculin reports additional positive interim results in adult glioblastoma trialMoleculin reports additional positive interim results in adult glioblastoma trial
seekingalpha.com - October 13 at 9:05 AM
Moleculin Announces New Antiviral Drug Candidates Demonstrate In Vitro Activity Against HIVMoleculin Announces New Antiviral Drug Candidates Demonstrate In Vitro Activity Against HIV
prnewswire.com - October 6 at 9:23 AM
Moleculin pipeline candidates show potential activity against HIVMoleculin pipeline candidates show potential activity against HIV
seekingalpha.com - October 6 at 9:23 AM
Moleculin Appoints Elizabeth Cermak to Board of DirectorsMoleculin Appoints Elizabeth Cermak to Board of Directors
prnewswire.com - October 5 at 8:32 AM
Moleculins WP1066 shows encouraging action in early-stage pediatric brain tumor studyMoleculin's WP1066 shows encouraging action in early-stage pediatric brain tumor study
seekingalpha.com - October 1 at 3:40 PM
Moleculin Announces Positive Interim Results in Pediatric Brain Tumor Phase 1 Clinical Trial at Emory UniversityMoleculin Announces Positive Interim Results in Pediatric Brain Tumor Phase 1 Clinical Trial at Emory University
prnewswire.com - October 1 at 10:39 AM
Moleculin to conduct in vitro for WP1096 in COVID-19, shares up 2%Moleculin to conduct in vitro for WP1096 in COVID-19, shares up 2%
seekingalpha.com - September 29 at 2:35 PM
Moleculin Biotech discovers additional anti-SARS-CoV-2 moleculeMoleculin Biotech discovers additional anti-SARS-CoV-2 molecule
seekingalpha.com - September 29 at 2:35 PM
Moleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New AntimetabolitesMoleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New Antimetabolites
prnewswire.com - September 29 at 9:35 AM
Moleculin to conduct in vivo for WP1122 in COVID-19Moleculin to conduct in vivo for WP1122 in COVID-19
seekingalpha.com - September 14 at 12:41 PM
Moleculin : COVID-19 In Vivo Testing Contracted For WP1122Moleculin : COVID-19 In Vivo Testing Contracted For WP1122
nasdaq.com - September 14 at 12:41 PM
Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122
finance.yahoo.com - September 14 at 7:40 AM
Moleculin to Present at Upcoming Healthcare Investor ConferencesMoleculin to Present at Upcoming Healthcare Investor Conferences
finance.yahoo.com - September 10 at 11:59 AM
BRK Extends its Footprint into Europe and CIS and "EV" Vehicles with Key AppointmentBRK Extends its Footprint into Europe and CIS and "EV" Vehicles with Key Appointment
finance.yahoo.com - September 9 at 3:01 PM
Moleculin Announces Successful Completion of Pre-IND Meeting with the FDAMoleculin Announces Successful Completion of Pre-IND Meeting with the FDA
finance.yahoo.com - September 9 at 10:00 AM
Moleculin to Present at LD Micro 500 Virtual Investor ConferenceMoleculin to Present at LD Micro 500 Virtual Investor Conference
finance.yahoo.com - August 27 at 10:40 AM
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.